Stock Forecast

  Khosla Ventures Acquisition Co. ( KVSA) Stock. Should you Buy or Sell?    $ 9.81

0.00 (0.00 %)



Khosla Ventures Acquisition Co. Analysis

Updated on 10-09-2022
Symbol KVSA
Price $9.81
Beta 0.000
Volume Avg. $156.14 thousand
Market Cap $397.17 M
52 Week Range $9.58 - $10.01


Khosla Ventures Acquisition Co. opened the day at $9.81 which is 0.00 % on yesterday's close. Khosla Ventures Acquisition Co. has a 52 week high of $10.01 and 52 week low of $9.58, which is a difference of $0.43. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $397.17 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy Khosla Ventures Acquisition Co. for $397.17 M, it would take 15 years to get your money back. Khosla Ventures Acquisition Co. are in the Shell Companies space which will have a sweet spot and industry standard for net profit multiples.



Price Chart


1 D | All


Financials




Khosla Ventures Acquisition Co. Stock Forecast - Is Khosla Ventures Acquisition Co. a Buy or Sell?


DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreNeutral
PE ScoreStrong Buy
PB ScoreNeutral
Overall RecommendationBuy

Growth and Value


PE Ratio 16.349
Dividend Yiel 0.000
Net Profit Margin 0.000


Valuing Khosla Ventures Acquisition Co.


Price Book Value Ratio 0.178 Price To Book Ratio 0.178
Price To Sales Ratio 0.000 Price Earnings Ratio -13.449


How liquid is Khosla Ventures Acquisition Co.


Current Ratio 0.126
Quick Ratio 0.023


Debt


Debt Ratio 0.048 Debt Equity Ratio 0.051
Long Term Debt To Capitalization 0.000 Total Debt To Capitalization 0.000



Latest news about Khosla Ventures Acquisition Co.


Nextdoor Plans IPO to Expand Local Social Networks in U.S. and Abroad

Neighborhood-oriented social network Nextdoor is entering the public markets via a SPAC merger with blank check company Khosla Ventures. Sarah Friar, Nextdoor CEO, joined Cheddar to discuss taking the IPO and how the company, already in one-in-three U.S. households, plans to expand both domestically and overseas.

Date : 08/07/2021

Khosla Ventures/Valo Health De-SPAC: Heed The Sponsor's Advice And Stay Away

Khosla Ventures/Valo Health De-SPAC: Heed The Sponsor's Advice And Stay Away

Date : 10/06/2021

Valo Health To Combine With Vinod Khosla-Backed SPAC In $2.8B Deal

Boston-based Valo Health LLC has agreed to go public through a reverse merger with a blank-check firm backed by venture capitalist Vinod Khosla, in a deal valuing the combined company at about $2.8 billion. Founded in 2019, Valo Health is a biotech company that uses data analysis and artificial intelligence to help drug discovery and development.

Date : 09/06/2021

The latest SPAC deal to know about: Valo Health to combine with Khosla Ventures Acquisition

Khosla Ventures Acquisition Co. (NASDAQ: KVSA), a special purpose acquisition vehicle (SPAC), and Valo Health LLC, a technology startup company, have entered into a definitive merger agreement to combine and take Valo Health public. Valo is a Boston-headquartered technology company that aims to accelerate the drug discovery and development process using its Opal Computational Platform […] The post The latest SPAC deal to know about: Valo Health to combine with Khosla Ventures Acquisition appeared first on Invezz.

Date : 09/06/2021





About Khosla Ventures Acquisition Co.


CEO : Mr. Samir Kaul
Sector : Financial Services
Industry : Shell Companies

Website : https://khoslaventuresacquisitionco.com/kvsa

Exchange : NASDAQ Capital Market

Description :

Khosla Ventures Acquisition Co. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Menlo Park, California.


My Newsletter

Sign Up For Updates & Newsletters